Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)

INTRODUCTION: Vincristine is an integral component of treatment for children with cancer. Its main dose‐limiting side effect is vincristine‐induced peripheral neuropathy (VIPN). The VINCA trial was a randomized controlled trial that explored the effect of 1‐hour infusion compared with push injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Uittenboogaard, Aniek, van den Berg, Marleen H., Abbink, Floor C. H., Twisk, Jos W. R., van der Sluis, Inge M., van den Bos, Cor, van den Heuvel‐Eibrink, Marry M., Segers, Heidi, Chantrain, Christophe, van der Werff ten Bosch, Jutte, Willems, Leen, Kaspers, Gertjan J. L., van de Velde, Mirjam Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587928/
https://www.ncbi.nlm.nih.gov/pubmed/37732486
http://dx.doi.org/10.1002/cam4.6550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587928/
https://www.ncbi.nlm.nih.gov/pubmed/37732486
http://dx.doi.org/10.1002/cam4.6550

Ejemplares similares